A National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition
AstraZeneca details ‘very ambitious’ strategy for early-stage obesity programs
AstraZeneca plans to develop treatment options for people with different BMIs as part of its “very ambitious” obesity strategy. AstraZeneca CEO Pascal Soriot on Thursday